Global burden of non-communicable diseases attributable to ambient fine particulate matter pollution in adults aged 65 years and older from 1990 to 2021

QJM. 2026 Jun 10:hcag147. doi: 10.1093/qjmed/hcag147. Online ahead of print.ABSTRACTBACKGROUND: Older adults are an important group affected by both non-communicable diseases (NCDs) and ambient fine particulate matter pollution (ambient PM2.5). This study aimed to estimate the disease burden of NCDs

Z Zhong Zheng

Coronary Artery Calcium Progression-A Useful Outcome in Clinical Trials?

No abstractJAMA Cardiol. 2026 Jun 10. doi: 10.1001/jamacardio.2026.1267. Online ahead of print.NO ABSTRACTPMID:42268628 | DOI:10.1001/jamacardio.2026.1267

M Michael J Blaha

Outcomes of Cardiovascular Surgery in Patients With Multiple Sclerosis

JAMA Surg. 2026 Jun 10. doi: 10.1001/jamasurg.2026.1951. Online ahead of print.ABSTRACTIMPORTANCE: Patients with multiple sclerosis (MS) have a higher incidence of heart failure and myocardial infarction. In patients with MS, autonomic dysregulation may cause detrimental hemodynamic instability peri

J Jose L Diz Ferre

Wearable Devices and Data Sharing in the US

JAMA Netw Open. 2026 Jun 1;9(6):e2617733. doi: 10.1001/jamanetworkopen.2026.17733.ABSTRACTIMPORTANCE: Large-scale efforts to expand the role of wearables in digital health require a contemporary assessment of patterns and drivers of wearable use, willingness to share data, and actual data sharing.OB

A Aline F Pedroso

Two Years of Menaquinone-7 Supplementation and Coronary Artery Calcification: A Randomized Clinical Trial

JAMA Cardiol. 2026 Jun 10. doi: 10.1001/jamacardio.2026.1279. Online ahead of print.ABSTRACTIMPORTANCE: Vitamin K supplementation can reduce progression of vascular calcification in patients with diabetes or end-stage kidney disease. Presently, it is unknown whether vitamin K is also beneficial in p

L Liv M Vossen

MiR-125a C > T, MiR-152 C > T, MiR-938 G > A, and MiR-491 G > A single nucleotide polymorphisms and their influence on genetic susceptibility to type 2 diabetes

Genes Genomics. 2026 Jun 10. doi: 10.1007/s13258-026-01781-9. Online ahead of print.ABSTRACTBACKGROUND: Diabetes mellitus (DM) is a chronic metabolic disorder that carries the risk of severe complications, such as cardiovascular disease, renal impairment, and an increased susceptibility to Alzheimer

S Sang A Choi

Combinations of single gene predictors with AI-driven polygenic precision therapies in cardiovascular diseases

Pharmacogenomics. 2026 Jun 10:1-8. doi: 10.1080/14622416.2026.2686336. Online ahead of print.ABSTRACTPharmacogenomics (PGx) is transforming how we treat cardiovascular disease (CVD) by enabling us to select and dose drugs based on our genetic profiles. The pharmacokinetics and pharmacodynamics of co

N Navakanth Raju Ramayanam

Proteomic insights: the downregulation of serotransferrin and its implications for coronary artery disease

Acta Cardiol. 2026 Jun 10:1-10. doi: 10.1080/00015385.2026.2684369. Online ahead of print.ABSTRACTCoronary artery disease (CAD) is a common cardiovascular condition characterised by the narrowing of the coronary arteries due to atherosclerosis, primarily resulting from the accumulation of plaque. It

P Prachi Agnihotri

Prognostic Value of Tricuspid Regurgitation in Pulmonary Hypertension and Among the Different WHO Groups

JACC Cardiovasc Imaging. 2026 Jun 10:S1936-878X(26)00260-3. doi: 10.1016/j.jcmg.2026.04.016. Online ahead of print.ABSTRACTBACKGROUND: Secondary tricuspid regurgitation (STR) is frequently observed in patients with pulmonary hypertension (PH). Whether it independently confers mortality risk beyond t

J Jwan A Naser

Heart Failure Duration, Cardiac Remodeling, Dysfunction, and Hemodynamic Severity in HFpEF and HFmrEF: Insights From REDUCE LAP-HF II

JACC Heart Fail. 2026 Jun 5:103167. doi: 10.1016/j.jchf.2026.103167. Online ahead of print.ABSTRACTBACKGROUND: Pathophysiologic features associated with increased risk in heart failure with preserved ejection fraction (HFpEF) may reflect distinct phenotypes or disease stages related to heart failure

S Shunichi Doi

Genotype Predicts Heart Failure Independent of LVEF, Peak VO2, and NT-proBNP Levels in Hypertrophic Cardiomyopathy

CONCLUSIONS: Genetic status, peak VO(2), log NT-proBNP, and LVEF independently predict HF outcomes in HCM. Combining genotype with HF biomarkers and functional capacity measures identifies patients at increased risk of HF-related death or transplant and may support targeted monitoring and selection

A Athanasios Bakalakos

Direct-to-Patient Prescription Drug Platforms: What Should Cardiologists Know?

No abstractJ Am Coll Cardiol. 2026 Jun 10:S0735-1097(26)06491-0. doi: 10.1016/j.jacc.2026.04.048. Online ahead of print.NO ABSTRACTPMID:42268161 | DOI:10.1016/j.jacc.2026.04.048

K Kavya M Shah

Angiographic Quantitative Flow Ratio-Guided Coronary Intervention: 5-Year Follow-Up From the FAVOR III China Randomized Trial

J Am Coll Cardiol. 2026 Jun 2:S0735-1097(26)06356-4. doi: 10.1016/j.jacc.2026.04.037. Online ahead of print.ABSTRACTBACKGROUND: The multicenter, randomized, sham-controlled FAVOR III China trial (Comparison of Quantitative Flow Ratio-Guided and Angiography-Guided Percutaneous Intervention in Patient

H Han Zhang

Complex interplay between disease and aerobic exercise training on vascular function in an exacerbated emphysema rat model

J Appl Physiol (1985). 2026 Jun 10. doi: 10.1152/japplphysiol.00155.2026. Online ahead of print.ABSTRACTAim: Chronic obstructive pulmonary disease (COPD) is a respiratory disease with systemic complications including vascular dysfunction. Aerobic exercise improves blood pressure, endothelial functio

E Elodie Desplanche

Cardiorespiratory Exercise Intensity Prescription in Cardiovascular Rehabilitation: Do Updated Guideline Recommendations Reflect Real Individual Effort Responses?

Eur J Prev Cardiol. 2026 Jun 10:zwag311. doi: 10.1093/eurjpc/zwag311. Online ahead of print.ABSTRACTAIMS: To evaluate how accurately the updated AHA/AACVPR Scientific Statement prescribes moderate-intensity exercise based on percentage of heart rate reserve (%HRR), by comparing it with heart rate (H

J Juliana Goulart Prata Oliveira Milani

Cardiovascular Disease Risk Among Young Adults with Disabilities: A Nationwide Cohort Study

Eur J Prev Cardiol. 2026 Jun 10:zwag321. doi: 10.1093/eurjpc/zwag321. Online ahead of print.ABSTRACTAIMS: Cardiovascular disease (CVD) risk may be under-recognized in young adults living with long-standing disability. We evaluated whether disability is associated with incident CVD risk in adults age

E Eunji Kim

Chronotropic incompetence in cardiovascular disease: a call for the establishment of a standardised and valid detection method

No abstractEur J Prev Cardiol. 2026 Jun 10:zwag315. doi: 10.1093/eurjpc/zwag315. Online ahead of print.NO ABSTRACTPMID:42267903 | DOI:10.1093/eurjpc/zwag315

D Dominique Hansen

Saddle pulmonary embolism with acute cor pulmonale in contemporary practice: Epidemiological trends and reperfusion strategies

Vasc Med. 2026 Jun;31(3):310-322. doi: 10.1177/1358863X261431264. Epub 2026 Jun 10.ABSTRACTBACKGROUND: Saddle pulmonary embolism (SPE) is defined as large emboli located at the bifurcation of the main pulmonary artery. The prevalence and optimal intervention for SPE remain unclear. Herein, we focus

W Wenzhu Li

Introducing the 2026 Focused Issue on Venous Disease: What excites us most about the future of this field

No abstractVasc Med. 2026 Jun;31(3):260-263. doi: 10.1177/1358863X261426953. Epub 2026 Jun 10.NO ABSTRACTPMID:42267762 | DOI:10.1177/1358863X261426953

H Heather L Gornik

Transcriptomic profiling of varicose veins and associated blood biomarkers

Vasc Med. 2026 Jun;31(3):264-271. doi: 10.1177/1358863X261434444. Epub 2026 Jun 10.ABSTRACTBACKGROUND: Intervention for patients with symptomatic varicose veins is largely driven by a combination of symptoms, the magnitude of venous reflux, clinical severity scoring algorithms, and unresponsiveness

A Anu Aggarwal

The Utility of Intravascular Ultrasound Evaluation in Addition to the Conventional Risk Factors for Predicting Restenosis After Endovascular Therapy Using Drug-Coated Balloon in Femoropopliteal Artery Lesions

J Endovasc Ther. 2026 Jun 10:15266028261453007. doi: 10.1177/15266028261453007. Online ahead of print.ABSTRACTPURPOSE: Baseline lesion characteristics have been reported to be associated with vessel patency after drug-coated balloon (DCB) treatment for femoropopliteal artery lesions. Intravascular u

H Hiroaki Akai

Cardiovascular Disease Subtypes and Alzheimer's Disease: Phenotypic and Genetic Associations in the UK Biobank and All of Us Research Program

J Am Heart Assoc. 2026 Jun 10:e046172. doi: 10.1161/JAHA.125.046172. Online ahead of print.ABSTRACTBACKGROUND: Cardiovascular disease (CVD) and Alzheimer's disease (AD) are major public health concerns that share overlapping risk factors and potential mechanistic pathways. Although vascular contribu

A Aili Toyli

Metabolic syndrome and cardiovascular risk among people living with HIV in Southwest Goias, Brazil: A cross-sectional study

AIDS Care. 2026 Jun 10:1-14. doi: 10.1080/09540121.2026.2683098. Online ahead of print.ABSTRACTThe study aims to assess the prevalence of metabolic syndrome (MetS) and cardiovascular risk (CVR), as well as their associations with clinical and sociodemographic characteristics, in people living with (

B Beatriz Toyama Watanabe

Subclinical right ventricular dysfunction in asthma: association with disease severity and control assessed by echocardiography

Monaldi Arch Chest Dis. 2026 Jun 9. doi: 10.4081/monaldi.2026.3895. Online ahead of print.ABSTRACTAsthma is a chronic inflammatory airway disease that may affect the cardiovascular system, particularly the right ventricle (RV). Early subclinical RV dysfunction in asthma remains insufficiently explor

A Asma Bouslimi